A secretory phospholipase A2-mediated neuroprotection and anti-apoptosis

BMC Neuroscience

Volumn 10, Issue , 2009, Pages 120-

  Armugam, Arunmozhiarasi ^a   Cher, Charmian D N ^a   Lim, KaiYing ^a   Koh, Dawn C I ^a   Howells, David W ^b   Jeyaseelan, Kandiah ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CASPASE 3; DIZOCILPINE; GLUCOSE; OXYGEN; SECRETORY PHOSPHOLIPASE A2; NEUROPROTECTIVE AGENT; PHOSPHOLIPASE A2; SNAKE VENOM; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTOMA CELL; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; SNAKE; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; ANOXIA; BRAIN; CEREBRAL ARTERY DISEASE; CHEMISTRY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METABOLISM; MICROARRAY ANALYSIS; NERVE CELL; ORGAN CULTURE TECHNIQUE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TUMOR CELL CULTURE;

ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; APOPTOSIS; BRAIN; BRAIN ISCHEMIA; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COBRA VENOMS; GLUCOSE; HIPPOCAMPUS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICROARRAY ANALYSIS; NEURONS; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; PHOSPHOLIPASES A2; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE PLASMINOGEN ACTIVATOR; TUMOR CELLS, CULTURED;

EID: 70349782431     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-10-120     Document Type: Article

References (52)

1. Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 1994, 269:13057-60.
2. Cummings BS, McHowat J, Schnellmann RG. Phospholipase A(2)s in cell injury and death. J Pharmacol Exp Ther 2000, 294:793-9.
3. Winstead MV, Balsinde J, Dennis EA. Calcium-independent phospholipase A(2): structure and function. Biochim Biophys Acta 2000, 1488:28-39.
4. Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 2002, 68-69:3-58. 10.1016/S0090-6980(02)00020-5, 12432908.
5. Sun GY, Xu J, Jensen MD, Simonyi A. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 2004, 45:205-13. 10.1194/jlr.R300016-JLR200, 14657205.
6. Liu NK, Zhang YP, Titsworth WL, Jiang X, Han S, Lu PH, Shields CB, Xu XM. A novel role of phospholipase A2 in mediating spinal cord secondary injury. Ann Neurol 2006, 59:606-19. 10.1002/ana.20798, 16498630.
7. Sun GY, Xu J, Jensen MD, Yu S, Wood WG, Gonzalez FA, Simonyi A, Sun AY, Weisman GA. Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G protein-coupled receptor agonists. Mol Neurobiol 2005, 31:27-41. 10.1385/MN:31:1-3:027, 15953810.
8. Farooqui AA, Ong WY, Horrocks LA. Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 2006, 58:591-620. 10.1124/pr.58.3.7, 16968951.
9. Moses GS, Jensen MD, Lue LF, Walker DG, Sun AY, Simonyi A, Sun GY. Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J Neuroinflammation 2006, 3:28. 10.1186/1742-2094-3-28, 1613236, 17026770.
10. Muralikrishna Adibhatla R, Hatcher JF. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 2006, 40:376-87. 10.1016/j.freeradbiomed.2005.08.044, 16443152.
11. Arai K, Ikegaya Y, Nakatani Y, Kudo I, Nishiyama N, Matsuki N. Phospholipase A2 mediates ischemic injury in the hippocampus: a regional difference of neuronal vulnerability. Eur J Neurosci 2001, 13:2319-23. 10.1046/j.0953-816x.2001.01623.x, 11454037.
12. Tabuchi S, Uozumi N, Ishii S, Shimizu Y, Watanabe T, Shimizu T. Mice deficient in cytosolic phospholipase A2 are less susceptible to cerebral ischemia/reperfusion injury. Acta Neurochir Suppl 2003, 86:169-72.
13. Strokin M, Chechneva O, Reymann KG, Reiser G. Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2. Neuroscience 2006, 140:547-53. 10.1016/j.neuroscience.2006.02.026, 16563639.
14. Gabryel B, Chalimoniuk M, Stolecka A, Langfort J. Activation of cPLA2 and sPLA2 in astrocytes exposed to simulated ischemia in vitro. Cell Biol Int 2007, 31:958-65. 10.1016/j.cellbi.2007.03.005, 17462919.
15. Harris JB, Grubb BD, Maltin CA, Dixon R. The neurotoxicity of the venom phospholipases A(2), notexin and taipoxin. Exp Neurol 2000, 161:517-26. 10.1006/exnr.1999.7275, 10686073.
16. Miyoshi S, Tu AT. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR. Arch Biochem Biophys 1999, 369:114-8. 10.1006/abbi.1999.1321, 10462446.
17. Valentin E, Lambeau G. What can venom phospholipases A(2) tell us about the functional diversity of mammalian secreted phospholipases A(2)?. Biochimie 2000, 82:815-31. 10.1016/S0300-9084(00)01168-8, 11086212.
18. Armugam A, Earnest L, Chung MC, Gopalakrishnakone P, Tan CH, Tan NH, Jeyaseelan K. Cloning and characterization of cDNAs encoding three isoforms of phospholipase A2 in Malayan spitting cobra (Naja naja sputatrix) venom. Toxicon 1997, 35:27-37. 10.1016/S0041-0101(96)00071-2, 9028006.
19. Jeyaseelan K, Armugam A, Donghui M, Tan NH. Structure and phylogeny of the venom group I phospholipase A(2) gene. Mol Biol Evol 2000, 17:1010-21.
20. Tan NH, Arunmozhiarasi A. The anticoagulant activity of Malayan cobra (Naja naja sputatrix) venom and venom phospholipase A2 enzymes. Biochem Int 1989, 19:803-10.
21. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
22. Engelhorn T, Doerfler A, Forsting M, Heusch G, Schulz R. Does a relative perfusion measure predict cerebral infarct size?. AJNR Am J Neuroradiol 2005, 26:2218-23.
23. Cher CD, Armugam A, Lachumanan R, Coghlan MW, Jeyaseelan K. Pulmonary inflammation and edema induced by phospholipase A2: global gene analysis and effects on aquaporins and Na+/K+-ATPase. J Biol Chem 2003, 278:31352-60. 10.1074/jbc.M302446200, 12746451.
24. Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991, 37:173-82. 10.1016/0165-0270(91)90128-M, 1715499.
25. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucl Acids Res 2002, 30:207-10. 10.1093/nar/30.1.207, 99122, 11752295.
26. Meng W, Wang X, Asahi M, Kano T, Asahi K, Ackerman RH, Lo EH. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1999, 19:1316-21. 10.1097/00004647-199912000-00004, 10598935.
27. Kilic E, Bahr M, Hermann DM. Effects of recombinant tissue plasminogen activator after intraluminal thread occlusion in mice: role of hemodynamic alterations. Stroke 2001, 32:2641-7. 10.1161/hs1101.097381, 11692029.
28. Bertorelli R, Adami M, Di Santo E, Ghezzi P. MK 801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain. Neurosci Lett 1998, 246:41-4. 10.1016/S0304-3940(98)00221-3, 9622203.
29. Adibhatla RM, Hatcher JF. Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat. Brain Res 2007, 1134:199-205. 10.1016/j.brainres.2006.11.080, 1855193, 17204250.
30. Van Cruchten S, Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol 2002, 31:214-23. 10.1046/j.1439-0264.2002.00398.x, 12196263.
31. Sturn A, Quackenbush J, Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 2002, 18:207-8. 10.1093/bioinformatics/18.1.207, 11836235.
32. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 2002, 31:19-20. 10.1038/ng0502-19, 11984561.
33. Saluja I, O'Regan MH, Song D, Phillis JW. Activation of cPLA2, PKC, and ERKs in the rat cerebral cortex during ischemia/reperfusion. Neurochem Res 1999, 24:669-77. 10.1023/A:1021004525979, 10344596.
34. Glover S, de Carvalho MS, Bayburt T, Jonas M, Chi E, Leslie CC, Gelb MH. Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J Biol Chem 1995, 270:15359-67. 10.1074/jbc.270.25.15359, 7797525.
35. Smith WS. Pathophysiology of focal cerebral ischemia: a therapeutic perspective. J Vasc Interv Radiol 2004, 15:S3-12.
36. Daniel B, DeCoster MA. Quantification of sPLA2-induced early and late apoptosis changes in neuronal cell cultures using combined TUNEL and DAPI staining. Brain Res Brain Res Protoc 2004, 13:144-50. 10.1016/j.brainresprot.2004.04.001, 15296851.
37. Pringle AK, Iannotti F, Wilde GJ, Chad JE, Seeley PJ, Sundstrom LE. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia. Brain Res 1997, 755:36-46. 10.1016/S0006-8993(97)00089-9, 9163539.
38. Wong EH, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 1986, 83:7104-8. 10.1073/pnas.83.18.7104, 386661, 3529096.
39. Gilroy DW, Newson J, Sawmynaden P, Willoughby DA, Croxtall JD. A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. Faseb J 2004, 18:489-98. 10.1096/fj.03-0837com, 15003994.
40. Forlenza OV, Mendes CT, Marie SK, Gattaz WF. Inhibition of phospholipase A2 reduces neurite outgrowth and neuronal viability. Prostaglandins Leukot Essent Fatty Acids 2007, 76:47-55. 10.1016/j.plefa.2006.10.002, 17187973.
41. Masuda S, Yamamoto K, Hirabayashi T, Ishikawa Y, Ishii T, Kudo I, Murakami M. Human group III secreted phospholipase A2 promotes neuronal outgrowth and survival. Biochem J 2008, 409:429-38. 10.1042/BJ20070844, 17868035.
42. Ikeno Y, Konno N, Cheon SH, Bolchi A, Ottonello S, Kitamoto K, Arioka M. Secretory phospholipases A2 induce neurite outgrowth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptor. J Biol Chem 2005, 280:28044-52. 10.1074/jbc.M503343200, 15927955.
43. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-6. 10.1126/science.281.5381.1322, 9735050.
44. Zha H, Reed JC. Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells. J Biol Chem 1997, 272:31482-8. 10.1074/jbc.272.50.31482, 9395483.
45. Kitagawa K, Matsumoto M, Tsujimoto Y, Ohtsuki T, Kuwabara K, Matsushita K, Yang G, Tanabe H, Martinou JC, Hori M. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke 1998, 29:2616-21.
46. Wang HD, Fukuda T, Suzuki T, Hashimoto K, Liou SY, Momoi T, Kosaka T, Yamamoto K, Nakanishi H. Differential effects of Bcl-2 overexpression on hippocampal CA1 neurons and dentate granule cells following hypoxic ischemia in adult mice. J Neurosci Res 1999, 57:1-12. 10.1002/(SICI)1097-4547(19990701)57:1<1::AID-JNR1>3.0.CO;2-Y, 10397630.
47. Bazan NG. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol 2005, 15:159-66.
48. Maeno E, Ishizaki Y, Kanaseki T, Hazama A, Okada Y. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci USA 2000, 97:9487-92. 10.1073/pnas.140216197, 16891, 10900263.
49. Jablonski EM, Webb AN, McConnell NA, Riley MC, Hughes FM. Plasma membrane aquaporin activity can affect the rate of apoptosis but is inhibited after apoptotic volume decrease. Am J Physiol Cell Physiol 2004, 286:C975-85. 10.1152/ajpcell.00180.2003, 14644770.
50. Papadopoulos MC, Saadoun S, Binder DK, Manley GT, Krishna S, Verkman AS. Molecular mechanisms of brain tumor edema. Neuroscience 2004, 129:1011-20. 10.1016/j.neuroscience.2004.05.044, 15561416.
51. Kobayashi H, Yanagita T, Yokoo H, Wada A. Molecular mechanisms and drug development in aquaporin water channel diseases: aquaporins in the brain. J Pharmacol Sci 2004, 96:264-70. 10.1254/jphs.FMJ04004X5, 15557735.
52. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-8.